Global Bio-chem Technology Group Company Limited
GBCMF
$0.005
$0.000.00%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 293.80M | 275.28M | 256.51M | 243.52M | 230.67M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 293.80M | 275.28M | 256.51M | 243.52M | 230.67M |
| Cost of Revenue | 253.50M | 241.10M | 228.46M | 218.77M | 209.20M |
| Gross Profit | 40.29M | 34.19M | 28.05M | 24.75M | 21.47M |
| SG&A Expenses | 40.75M | 43.10M | 45.41M | 47.59M | 49.78M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -4.67M | -2.35M | -27.80K | -4.31M | -8.58M |
| Total Operating Expenses | 289.59M | 281.85M | 273.84M | 262.05M | 250.40M |
| Operating Income | 4.21M | -6.56M | -17.33M | -18.53M | -19.73M |
| Income Before Tax | 96.15M | 95.98M | 95.84M | 278.42M | 460.86M |
| Income Tax Expenses | -3.08M | -3.08M | -3.08M | -2.28M | -1.48M |
| Earnings from Continuing Operations | 99.23 | 99.06 | 98.92 | 280.69 | 462.34 |
| Earnings from Discontinued Operations | -- | -- | -- | 34.99M | 69.93M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -1.93M | -3.86M |
| Net Income | 99.23M | 99.06M | 98.92M | 313.75M | 528.41M |
| EBIT | 4.21M | -6.56M | -17.33M | -18.53M | -19.73M |
| EBITDA | 21.21M | 15.56M | 9.91M | 11.63M | 13.36M |
| EPS Basic | 0.01 | 0.01 | 0.01 | 0.04 | 0.06 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | -0.01 | -0.01 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.01 | 0.03 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 |
| Average Basic Shares Outstanding | 35.71B | 35.71B | 35.71B | 35.67B | 35.63B |
| Average Diluted Shares Outstanding | 104.79B | 104.79B | 104.79B | 80.55B | 56.32B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |